
News|Articles|March 6, 2023
Daily Dose: Mediterranean Diet & Risk of CVD in Women
Author(s)Sydney Jennings
Your daily dose of clinical news you may have missed.
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On March 3, 2023, we reported on a study abstract presented at the American College of Cardiology’s (ACC) 72nd Annual Scientific Session Together with the World Congress of Cardiology, being held March 4-6, 2023, in New Orleans.
The study
Researchers conducted a systematic review and meta-analysis to determine the association of higher versus lower adherence to a Mediterranean diet with incident cardiovascular disease (CVD) and total mortality in women. Investigators searched Medline, Embase, Scopus, and other databases for randomized controlled trials and prospective cohort studies that included participants without a previous CVD diagnosis. Studies were deemed eligible if they reported a Mediterranean diet score and included only women or stratified outcomes by sex. The primary outcome of the current study was CVD and/or total mortality, according to the abstract. A total of 16 prospective cohort studies were included in the meta-analysis (N=722 495 women).
Researchers observed that in women, a higher adherence to a Mediterranean diet was associated with lower CVD incidence (hazard ratio [HR] 0.76, 95% CI 0.72-0.81; I2=39%, Pheterogeneity=.07), total mortality (HR 0.77, 95% CI 0.74-0.80; I2=21%, Pheterogeneity=.28), and coronary heart disease (HR 0.75, 95% CI 0.65-0.87; I2=21%, Pheterogeneity=.28). Stroke incidence was lower in women with a higher Mediterranean diet adherence (HR 0.87, 95% CI 0.76-1.01; I2=0%, Pheterogeneity=.89) without statistical significance.
Note from authors
“This study supports a beneficial effect of the Mediterranean diet on primary prevention of CVD and death in women and is an important step in enabling sex-specific guidelines.”
Click here for more details.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management
2
Zasocitinib Demonstrates Superiority vs Placebo and Apremilast in Phase 3 Plaque Psoriasis Trials
3
FDA Approves Lerodalcibep, Third-Generation PCSK9 Inhibitor, to Treat Hypercholesterolemia, Including HeFH
4
In CRC Screening, Progress Looks More Like Improved Follow-Through vs Next Breakthrough: Discussion with Mark Fendrick, MD
5

















































































































































































































































































